Aromatase Inhibitors vs. Tamoxifen: What Should Women Do?
芳香酶抑制剂比他莫昔芬：女性应该做什么？
Hormone therapy includes tamoxifen and aromatase inhibitors.
激素治疗包括三苯氧胺和芳香酶抑制剂。
The much higher cost of the aromatase inhibitors has been an issue for some women.
对一些女性来说，芳香酶抑制剂高的多的花费一直是一个问题。
It was also unclear why the aromatase inhibitors were causing these aches and pains.
也不清楚为什么芳香酶抑制剂会导致这些疼痛和痛苦。
These women had outcomes similar to those seen in women treated with aromatase inhibitors.
其治疗效果与使用芳香酶抑制剂治疗的妇女的治疗效果相似。
The new aromatase inhibitors are highly selective and very well tolerated by patients clinically.
新一代芳香酶抑制剂的选择性高，耐受性好，目前在临床上得到广泛的应用。
Aromatase inhibitors are increasingly being used to prevent breast cancer recurrences in postmenopausal women.
芳香酶抑制剂正越来越多地被用来防止乳腺癌复发的绝经后妇女。
Unlike tamoxifen, aromatase inhibitors do not cause menopausal symptoms, but they may increase risk of osteoporosis.
与三苯氧胺不同的是，芳香抑制剂不会引起绝经期症状，但可增加骨质疏松症危险。
An expert who worked on the landmark ATAC study that first showed the effectiveness of aromatase inhibitors disagrees.
工作于首次显示芳香酶抑制剂有效性的标志atac研究的一个专家不同意。
We don't know exactly why the pain occurs, but it can be very debilitating — to the point that patients decide to stop taking aromatase inhibitors.
我们不知道疼痛发生的准确原因，但是这种疼痛使人变得很虚弱，以至于患者会决定停止服用芳香化酶抑制剂。
In this paper, the development, mechanism of action, the current clinical status and possible future applications of the aromatase inhibitors are reviewed.
本文主要对芳香酶抑制剂的研究进展、药理作用机理、临床应用和可能的应用前景等做一综述。
"Duloxetine appears to be effective at reducing the muscle and joint pain many women experience from aromatase inhibitors, with only mild additional side effects," Henry says.
“度洛西丁似乎能有效缓解妇女们因服用芳香化酶抑制剂而经受的减轻肌肉和关节疼痛，却只伴有很小的副作用。”亨利说道。
Recent evidence shows aromatase inhibitors used alone or in follow-up after two years of tamoxifen therapy demonstrates clear and, in some cases, improved reduction of recurrence risk.
近年来证据显示芳香酶抑制剂单独或在三苯氧胺使用两年后来进行治疗乳腺癌可以促进降低复发率。
Aromatase inhibitors have recently been proven more effective than tamoxifen and are becoming the preferred treatment for early-stage breast cancer in receptor-positive postmenopausal patients.
最近证明，芳香酶抑制剂比三苯氧胺更有效，它已成为受体阳性绝经后妇女早期乳腺癌治疗的首选药物。
Aromatase inhibitors have recently been proven more effective than tamoxifen and are becoming the preferred treatment for early-stage breast cancer in receptor-positive postmenopausal patients.
最近证明，芳香酶抑制剂比三苯氧胺更有效，它已成为受体阳性绝经后妇女早期乳腺癌治疗的首选药物。
应用推荐